Testing effectiveness (Phase 2)Study completedNCT00000712
What this trial is testing
A Multicenter, Double Blind, Comparative Study of Zidovudine Alone Versus Zidovudine and Acyclovir as Treatment for HIV-Infected Patients With CD4+ Counts Less Than 200 Cells/mm3
Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 400